• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023

    8/16/23 11:00:44 AM ET
    $AMTX
    $AVAL
    $BRX
    $CBFV
    Major Chemicals
    Industrials
    Commercial Banks
    Finance
    Get the next $AMTX alert in real time by email

    Upgrades

    UBS upgraded the previous rating for Aemetis Inc (NASDAQ:AMTX) from Neutral to Buy. For the second quarter, Aemetis had an EPS of $0.68, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $10.74 and a 52-week-low of $1.16. At the end of the last trading period, Aemetis closed at $6.16.

    According to Exane BNP Paribas, the prior rating for Revance Therapeutics Inc (NASDAQ:RVNC) was changed from Underperform to Neutral. In the second quarter, Revance Therapeutics showed an EPS of $0.80, compared to $0.88 from the year-ago quarter. The current stock performance of Revance Therapeutics shows a 52-week-high of $37.98 and a 52-week-low of $17.97. Moreover, at the end of the last trading period, the closing price was at $18.80.

    For Inter & Co Inc (NASDAQ:INTR), Citigroup upgraded the previous rating of Neutral to Buy. For the second quarter, Inter & Co had an EPS of $0.02, compared to year-ago quarter EPS of $0.01. At the moment, the stock has a 52-week-high of $4.63 and a 52-week-low of $1.37. Inter & Co closed at $3.94 at the end of the last trading period.

    Evercore ISI Group upgraded the previous rating for Magnite Inc (NASDAQ:MGNI) from In-Line to Outperform. For the second quarter, Magnite had an EPS of $0.09, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $15.73 and a 52-week-low of $5.58. Magnite closed at $8.52 at the end of the last trading period.

    For National CineMedia Inc (NASDAQ:NCMI), Benchmark upgraded the previous rating of Hold to Speculative Buy. National CineMedia earned $0.08 in the fourth quarter, compared to $0.05 in the year-ago quarter. The current stock performance of National CineMedia shows a 52-week-high of $18.20 and a 52-week-low of $1.01. Moreover, at the end of the last trading period, the closing price was at $3.55.

    JP Morgan upgraded the previous rating for Gulfport Energy Corp (NYSE:GPOR) from Neutral to Overweight. In the second quarter, Gulfport Energy showed an EPS of $2.66, compared to $5.09 from the year-ago quarter. The current stock performance of Gulfport Energy shows a 52-week-high of $114.88 and a 52-week-low of $60.15. Moreover, at the end of the last trading period, the closing price was at $112.23.

    JP Morgan upgraded the previous rating for SM Energy Co (NYSE:SM) from Neutral to Overweight. For the second quarter, SM Energy had an EPS of $1.28, compared to year-ago quarter EPS of $2.19. The current stock performance of SM Energy shows a 52-week-high of $48.54 and a 52-week-low of $24.66. Moreover, at the end of the last trading period, the closing price was at $39.01.

    According to JP Morgan, the prior rating for Pioneer Natural Resources Co (NYSE:PXD) was changed from Neutral to Overweight. In the second quarter, Pioneer Natural Resources showed an EPS of $4.49, compared to $9.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $274.42 and a 52-week-low of $177.26. Pioneer Natural Resources closed at $233.72 at the end of the last trading period.

    BMO Capital upgraded the previous rating for CareTrust REIT Inc (NYSE:CTRE) from Market Perform to Outperform. In the second quarter, CareTrust REIT showed an EPS of $0.35, compared to $0.37 from the year-ago quarter. The current stock performance of CareTrust REIT shows a 52-week-high of $22.09 and a 52-week-low of $16.22. Moreover, at the end of the last trading period, the closing price was at $19.89.

    According to Citigroup, the prior rating for Callon Petroleum Co (NYSE:CPE) was changed from Neutral to Buy. In the second quarter, Callon Petroleum showed an EPS of $1.99, compared to $3.68 from the year-ago quarter. At the moment, the stock has a 52-week-high of $50.10 and a 52-week-low of $28.91. Callon Petroleum closed at $35.59 at the end of the last trading period.

    According to Mizuho, the prior rating for Permian Resources Corp (NYSE:PR) was changed from Neutral to Buy. At the moment, the stock has a 52-week-high of $12.62 and a 52-week-low of $6.12. Permian Resources closed at $12.16 at the end of the last trading period.

    According to Mizuho, the prior rating for Matador Resources Co (NYSE:MTDR) was changed from Neutral to Buy. In the second quarter, Matador Resources showed an EPS of $1.42, compared to $3.47 from the year-ago quarter. The current stock performance of Matador Resources shows a 52-week-high of $73.76 and a 52-week-low of $42.04. Moreover, at the end of the last trading period, the closing price was at $57.82.

    For Chevron Corp (NYSE:CVX), Mizuho upgraded the previous rating of Neutral to Buy. For the second quarter, Chevron had an EPS of $3.08, compared to year-ago quarter EPS of $5.82. At the moment, the stock has a 52-week-high of $189.66 and a 52-week-low of $140.48. Chevron closed at $159.24 at the end of the last trading period.

    For NextDecade Corp (NASDAQ:NEXT), Wolfe Research upgraded the previous rating of Peer Perform to Outperform. For the first quarter, NextDecade had an EPS of $0.23, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $8.94 and a 52-week-low of $3.92. NextDecade closed at $5.91 at the end of the last trading period.

    According to Goldman Sachs, the prior rating for Brixmor Property Group Inc (NYSE:BRX) was changed from Neutral to Buy. Brixmor Property Group earned $0.52 in the second quarter, compared to $0.49 in the year-ago quarter. The stock has a 52-week-high of $24.49 and a 52-week-low of $17.62. At the end of the last trading period, Brixmor Property Group closed at $22.21.

    According to UBS, the prior rating for Keurig Dr Pepper Inc (NASDAQ:KDP) was changed from Neutral to Buy. For the second quarter, Keurig Dr Pepper had an EPS of $0.42, compared to year-ago quarter EPS of $0.39. The stock has a 52-week-high of $41.25 and a 52-week-low of $30.47. At the end of the last trading period, Keurig Dr Pepper closed at $33.47.

    See all analyst ratings upgrades.

    Downgrades

    According to B of A Securities, the prior rating for SolarEdge Technologies Inc (NASDAQ:SEDG) was changed from Buy to Neutral. SolarEdge Technologies earned $2.62 in the second quarter, compared to $0.95 in the year-ago quarter. The current stock performance of SolarEdge Technologies shows a 52-week-high of $345.80 and a 52-week-low of $169.86. Moreover, at the end of the last trading period, the closing price was at $170.00.

    HC Wainwright & Co. downgraded the previous rating for Alaunos Therapeutics Inc (NASDAQ:TCRT) from Buy to Neutral. For the second quarter, Alaunos Therapeutics had an EPS of $0.04, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $4.01 and a 52-week-low of $0.12. At the end of the last trading period, Alaunos Therapeutics closed at $0.14.

    For Magellan Midstream Partners LP (NYSE:MMP), Argus Research downgraded the previous rating of Hold to Sell. Magellan Midstream earned $1.23 in the second quarter, compared to $1.17 in the year-ago quarter. The stock has a 52-week-high of $66.78 and a 52-week-low of $45.55. At the end of the last trading period, Magellan Midstream closed at $65.55.

    According to DA Davidson, the prior rating for Southland Holdings Inc (AMEX:SLND) was changed from Buy to Neutral. At the moment, the stock has a 52-week-high of $10.85 and a 52-week-low of $5.66. Southland Holdings closed at $6.41 at the end of the last trading period.

    For Marqeta Inc (NASDAQ:MQ), BTIG downgraded the previous rating of Neutral to Sell. For the second quarter, Marqeta had an EPS of $0.11, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $8.71 and a 52-week-low of $3.46. At the end of the last trading period, Marqeta closed at $5.88.

    For Galera Therapeutics Inc (NASDAQ:GRTX), HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. Galera Therapeutics earned $0.48 in the second quarter, compared to $0.54 in the year-ago quarter. The current stock performance of Galera Therapeutics shows a 52-week-high of $3.59 and a 52-week-low of $0.25. Moreover, at the end of the last trading period, the closing price was at $0.27.

    For Chesapeake Energy Corp (NASDAQ:CHK), JP Morgan downgraded the previous rating of Overweight to Neutral. For the second quarter, Chesapeake Energy had an EPS of $0.64, compared to year-ago quarter EPS of $4.87. At the moment, the stock has a 52-week-high of $107.31 and a 52-week-low of $69.68. Chesapeake Energy closed at $82.87 at the end of the last trading period.

    According to Mizuho, the prior rating for Magnolia Oil & Gas Corp (NYSE:MGY) was changed from Buy to Neutral. In the second quarter, Magnolia Oil & Gas showed an EPS of $0.51, compared to $1.32 from the year-ago quarter. The stock has a 52-week-high of $27.54 and a 52-week-low of $18.17. At the end of the last trading period, Magnolia Oil & Gas closed at $22.68.

    According to Mizuho, the prior rating for HF Sinclair Corp (NYSE:DINO) was changed from Buy to Neutral. In the second quarter, HF Sinclair showed an EPS of $2.60, compared to $5.59 from the year-ago quarter. At the moment, the stock has a 52-week-high of $66.17 and a 52-week-low of $37.12. HF Sinclair closed at $55.77 at the end of the last trading period.

    For Marathon Petroleum Corp (NYSE:MPC), Mizuho downgraded the previous rating of Buy to Neutral. In the second quarter, Marathon Petroleum showed an EPS of $5.32, compared to $10.61 from the year-ago quarter. At the moment, the stock has a 52-week-high of $149.76 and a 52-week-low of $89.41. Marathon Petroleum closed at $142.62 at the end of the last trading period.

    According to RBC Capital, the prior rating for Easterly Government Properties Inc (NYSE:DEA) was changed from Sector Perform to Underperform. In the second quarter, Easterly Government Props showed an EPS of $0.28, compared to $0.33 from the year-ago quarter. The current stock performance of Easterly Government Props shows a 52-week-high of $19.41 and a 52-week-low of $12.27. Moreover, at the end of the last trading period, the closing price was at $14.22.

    According to Canaccord Genuity, the prior rating for Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) was changed from Buy to Hold. Zynerba Pharmaceuticals earned $0.21 in the second quarter, compared to $0.24 in the year-ago quarter. At the moment, the stock has a 52-week-high of $1.38 and a 52-week-low of $0.25. Zynerba Pharmaceuticals closed at $1.35 at the end of the last trading period.

    For Golar LNG Ltd (NASDAQ:GLNG), Wolfe Research downgraded the previous rating of Outperform to Peer Perform. In the second quarter, Golar LNG showed an EPS of $0.04, compared to $2.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $30.65 and a 52-week-low of $19.62. Golar LNG closed at $22.39 at the end of the last trading period.

    According to JP Morgan, the prior rating for Grupo Aval Acciones y Valores SA (NYSE:AVAL) was changed from Neutral to Underweight. Grupo Aval Acciones earned $0.08 in the third quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.48 and a 52-week-low of $2.02. Grupo Aval Acciones closed at $2.45 at the end of the last trading period.

    According to Goldman Sachs, the prior rating for Kimco Realty Corp (NYSE:KIM) was changed from Buy to Neutral. In the second quarter, Kimco Realty showed an EPS of $0.39, compared to $0.40 from the year-ago quarter. The stock has a 52-week-high of $23.89 and a 52-week-low of $17.34. At the end of the last trading period, Kimco Realty closed at $19.81.

    According to Goldman Sachs, the prior rating for Tanger Factory Outlet Centers Inc (NYSE:SKT) was changed from Buy to Neutral. For the second quarter, Tanger Factory Outlet had an EPS of $0.47, compared to year-ago quarter EPS of $0.45. The stock has a 52-week-high of $25.23 and a 52-week-low of $13.26. At the end of the last trading period, Tanger Factory Outlet closed at $24.57.

    Keefe, Bruyette & Woods downgraded the previous rating for CB Financial Services Inc (NASDAQ:CBFV) from Outperform to Market Perform. For the second quarter, CB Financial Services had an EPS of $0.63, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $24.98 and a 52-week-low of $17.20. At the end of the last trading period, CB Financial Services closed at $22.67.

    According to Citigroup, the prior rating for Sea Ltd (NYSE:SE) was changed from Buy to Neutral. In the second quarter, Sea showed an EPS of $0.54, compared to $1.03 from the year-ago quarter. The stock has a 52-week-high of $92.20 and a 52-week-low of $40.11. At the end of the last trading period, Sea closed at $40.58.

    See all analyst ratings downgrades.

    Initiations

    Capital One initiated coverage on Immunocore Holdings PLC (NASDAQ:IMCR) with an Overweight rating. The price target for Immunocore Hldgs is set to $84.00. For the second quarter, Immunocore Hldgs had an EPS of $0.37, compared to year-ago quarter EPS of $0.17. At the moment, the stock has a 52-week-high of $69.01 and a 52-week-low of $39.00. Immunocore Hldgs closed at $60.25 at the end of the last trading period.

    With an Overweight rating, Wells Fargo initiated coverage on GE HealthCare Technologies Inc (NASDAQ:GEHC). The price target seems to have been set at $90.00 for GE HealthCare Techs. For the second quarter, GE HealthCare Techs had an EPS of $0.92, compared to year-ago quarter EPS of $1.15. The stock has a 52-week-high of $87.83 and a 52-week-low of $53.00. At the end of the last trading period, GE HealthCare Techs closed at $70.54.

    Barclays initiated coverage on Fortrea Holdings Inc (NASDAQ:FTRE) with a Equal-Weight rating. The price target for Fortrea Holdings is set to $29.00. For the second quarter, Fortrea Holdings had an EPS of $0.52, compared to year-ago quarter EPS of $0.97. At the moment, the stock has a 52-week-high of $37.30 and a 52-week-low of $25.68. Fortrea Holdings closed at $27.18 at the end of the last trading period.

    With a Buy rating, Guggenheim initiated coverage on Vera Therapeutics Inc (NASDAQ:VERA). The price target seems to have been set at $27.00 for Vera Therapeutics. For the second quarter, Vera Therapeutics had an EPS of $0.46, compared to year-ago quarter EPS of $0.55. The current stock performance of Vera Therapeutics shows a 52-week-high of $23.29 and a 52-week-low of $5.20. Moreover, at the end of the last trading period, the closing price was at $17.69.

    See all analyst ratings initiations.

    Get the next $AMTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMTX
    $AVAL
    $BRX
    $CBFV

    CompanyDatePrice TargetRatingAnalyst
    NextDecade Corporation
    $NEXT
    2/6/2026$7.00Overweight
    CapitalOne
    Marathon Petroleum Corporation
    $MPC
    2/4/2026$183.00 → $198.00Buy
    TD Cowen
    Chevron Corporation
    $CVX
    2/2/2026$160.00 → $168.00Hold
    TD Cowen
    Chevron Corporation
    $CVX
    2/2/2026$180.00Buy → Hold
    HSBC Securities
    Matador Resources Company
    $MTDR
    1/27/2026$47.00Overweight → Equal Weight
    Wells Fargo
    Magnolia Oil & Gas Corporation
    $MGY
    1/27/2026$22.00Underweight → Equal Weight
    Wells Fargo
    CareTrust REIT Inc.
    $CTRE
    1/22/2026$44.00Mkt Outperform
    Citizens JMP
    Chevron Corporation
    $CVX
    1/20/2026$176.00Neutral → Overweight
    Analyst
    More analyst ratings

    $AMTX
    $AVAL
    $BRX
    $CBFV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CapitalOne initiated coverage on NextDecade with a new price target

    CapitalOne initiated coverage of NextDecade with a rating of Overweight and set a new price target of $7.00

    2/6/26 8:35:07 AM ET
    $NEXT
    Oil & Gas Production
    Utilities

    TD Cowen reiterated coverage on Marathon Petroleum with a new price target

    TD Cowen reiterated coverage of Marathon Petroleum with a rating of Buy and set a new price target of $198.00 from $183.00 previously

    2/4/26 7:58:31 AM ET
    $MPC
    Integrated oil Companies
    Energy

    TD Cowen reiterated coverage on Chevron with a new price target

    TD Cowen reiterated coverage of Chevron with a rating of Hold and set a new price target of $168.00 from $160.00 previously

    2/2/26 7:18:00 AM ET
    $CVX
    Integrated oil Companies
    Energy

    $AMTX
    $AVAL
    $BRX
    $CBFV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Enright Patrick G bought $249,985 worth of shares (5,882 units at $42.50) (SEC Form 4)

    4 - Vera Therapeutics, Inc. (0001831828) (Issuer)

    12/15/25 8:07:34 PM ET
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Hanwha Aerospace Co., Ltd. bought $9,399,378 worth of shares (1,651,971 units at $5.69) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/15/25 7:12:58 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Large owner Hanwha Aerospace Co., Ltd. bought $5,742,414 worth of shares (932,598 units at $6.16) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/10/25 8:15:10 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    $AMTX
    $AVAL
    $BRX
    $CBFV
    Leadership Updates

    Live Leadership Updates

    View All

    Tractor Supply Company Raises Dividend; Expands Its Board of Directors With Appointment of Sonia Syngal

    Tractor Supply Company (NASDAQ: TSCO), the largest rural lifestyle retailer in the United States (the "Company"), today announced that its Board of Directors has increased its dividend by $0.04, or 4.3% year-over-year, to $0.96 per share on an annualized basis for 2026, marking the Company's 17th consecutive year of dividend increases. In accordance with this increase, the Board of Directors has declared a quarterly cash dividend of $0.24 per share of the Company's common stock. The dividend will be paid on March 10, 2026, to stockholders of record of the Company's common stock as of the close of business on February 24, 2026. Separately, the Board of Directors announce the appointment of

    2/11/26 9:00:00 AM ET
    $GAP
    $SKT
    $TSCO
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary
    Real Estate Investment Trusts
    Real Estate

    Vera Therapeutics Announces Appointment of Matt Skelton to Chief Commercial Officer

    BRISBANE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Matt Skelton to Chief Commercial Officer, effective immediately. Mr. Skelton joined Vera Therapeutics over a year ago as the Executive Vice President, Commercial. "We are pleased to welcome Matt to the executive team as we prepare for the potential commercial launch of atacicept for the treatment of IgA nephropathy," said Marshall Fordyce, M.D., Founder and CEO of Vera Therapeutics. "With his track record

    1/28/26 7:30:00 AM ET
    $VERA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    $AMTX
    $AVAL
    $BRX
    $CBFV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Morais Mark A. converted options into 2,255 shares and sold $16,365 worth of shares (1,179 units at $13.88), increasing direct ownership by 2% to 58,052 units (SEC Form 4)

    4 - Fortrea Holdings Inc. (0001965040) (Issuer)

    2/11/26 7:04:31 PM ET
    $FTRE
    Medical Specialities
    Health Care

    Chief Financial Officer Mcconnell Jill G. sold $12,229 worth of shares (881 units at $13.88) and converted options into 1,685 shares, increasing direct ownership by 1% to 59,574 units (SEC Form 4)

    4 - Fortrea Holdings Inc. (0001965040) (Issuer)

    2/11/26 7:02:25 PM ET
    $FTRE
    Medical Specialities
    Health Care

    Amendment: New insider Sharp Bruce A. claimed ownership of 5,776 shares (SEC Form 3)

    3/A - CB Financial Services, Inc. (0001605301) (Issuer)

    2/9/26 4:31:06 PM ET
    $CBFV
    Major Banks
    Finance

    $AMTX
    $AVAL
    $BRX
    $CBFV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chevron Enters Libya With New Block Award as Part of Broader Exploration Growth Strategy

    Chevron Corporation (NYSE:CVX) by its subsidiary Chevron Business Development EMEA Ltd., has entered Libya after it was designated as a winning bidder in the 2025 Libyan Bid Round. This follows the signing of a Memorandum of Understanding (MoU) with the country's National Oil Corporation (NOC). Chevron was designated as the winning bidder for Contract Area 106 located in the Sirte Basin on February 11, 2026 in Libya's 2025 Bidding Round. On January 24, 2026 Chevron separately signed an MoU with NOC in Tripoli to evaluate the development and exploration potential onshore Libya. "Chevron is excited to enter Libya with the award of onshore Contract Area 106, which underscores our focus on

    2/11/26 9:15:00 AM ET
    $CVX
    Integrated oil Companies
    Energy

    Tractor Supply Company Raises Dividend; Expands Its Board of Directors With Appointment of Sonia Syngal

    Tractor Supply Company (NASDAQ: TSCO), the largest rural lifestyle retailer in the United States (the "Company"), today announced that its Board of Directors has increased its dividend by $0.04, or 4.3% year-over-year, to $0.96 per share on an annualized basis for 2026, marking the Company's 17th consecutive year of dividend increases. In accordance with this increase, the Board of Directors has declared a quarterly cash dividend of $0.24 per share of the Company's common stock. The dividend will be paid on March 10, 2026, to stockholders of record of the Company's common stock as of the close of business on February 24, 2026. Separately, the Board of Directors announce the appointment of

    2/11/26 9:00:00 AM ET
    $GAP
    $SKT
    $TSCO
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary
    Real Estate Investment Trusts
    Real Estate

    New York Times Advertising and Magnite Enter Strategic Collaboration for In-App Supply

    NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- New York Times Advertising, the award-winning advertising team within The New York Times, and Magnite (NASDAQ:MGNI), the largest independent sell-side advertising company, today announced an expanded collaboration to make Magnite's DV+ the preferred platform for private marketplace deals for The New York Times's mobile in-app ad supply. The collaboration enables advertisers to connect with premium audiences across trusted in-app environments across The New York Times portfolio and achieve meaningful advertising campaign outcomes. According to EMARKETER, mobile in-app advertising is projected to grow 24% by 2027 as audiences spend more time in pr

    2/11/26 8:00:00 AM ET
    $MGNI
    Computer Software: Programming Data Processing
    Technology

    $AMTX
    $AVAL
    $BRX
    $CBFV
    SEC Filings

    View All

    SEC Form 6-K filed by Inter & Co. Inc.

    6-K - Inter & Co, Inc. (0001864163) (Filer)

    2/11/26 6:26:25 AM ET
    $INTR
    Commercial Banks
    Finance

    SEC Form 6-K filed by Inter & Co. Inc.

    6-K - Inter & Co, Inc. (0001864163) (Filer)

    2/11/26 6:07:28 AM ET
    $INTR
    Commercial Banks
    Finance

    SEC Form 6-K filed by Inter & Co. Inc.

    6-K - Inter & Co, Inc. (0001864163) (Filer)

    2/11/26 6:02:45 AM ET
    $INTR
    Commercial Banks
    Finance

    $AMTX
    $AVAL
    $BRX
    $CBFV
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for DAXXIFY issued to REVANCE THERAPEUTICS, INC.

    Submission status for REVANCE THERAPEUTICS, INC.'s drug DAXXIFY (SUPPL-2) with active ingredient DAXIBOTULINUMTOXINA-LANM has changed to 'Approval' on 08/11/2023. Application Category: BLA, Application Number: 761127, Application Classification:

    8/14/23 4:38:56 AM ET
    $RVNC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DAXXIFY issued to REVANCE THERAPEUTICS, INC.

    Submission status for REVANCE THERAPEUTICS, INC.'s drug DAXXIFY (ORIG-1) with active ingredient daxibotulinumtoixnA-lanm has changed to 'Approval' on 09/07/2022. Application Category: BLA, Application Number: 761127, Application Classification:

    9/8/22 1:11:06 PM ET
    $RVNC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMTX
    $AVAL
    $BRX
    $CBFV
    Financials

    Live finance-specific insights

    View All

    Inter&Co Reports Record Results, Driven by 36% Credit Expansion and 45% Net Income Growth in 2025

    MIAMI, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ:INTR) the leading digital bank providing financial and commerce services to over 43 million customers, reported its financial results today for the fourth quarter of 2025. 2025 Highlights:Inter delivered another year of exceptional growth across key metrics, sustaining consistent profitability while accelerating market expansion. Client Growth: Added a record-breaking 4.4 million new active clients in 2025, bringing total active clients to 25 million.Credit Expansion: Expanded the credit portfolio by 36% year-over-year, more than three times the growth rate of the Brazilian market, driven by strategic products like Private Pa

    2/11/26 7:13:25 AM ET
    $INTR
    Commercial Banks
    Finance

    Gulfport Energy Schedules Fourth Quarter and Full Year 2025 Earnings Release and 2026 Outlook Conference Call

    Gulfport Energy Corporation (NYSE:GPOR) announced today that it will host a teleconference and webcast to discuss its fourth quarter and full year 2025 financial and operating results, as well as its 2026 outlook, beginning at 10:00 a.m. ET (9:00 a.m. CT) on Wednesday, February 25, 2026. Gulfport plans to announce fourth quarter and full year 2025 results on Tuesday, February 24, 2026, after market close. The conference call can be heard live through a link on the Gulfport website, www.gulfportenergy.com. In addition, you may participate in the conference call by dialing 866-373-3408 domestically or 412-902-1039 internationally. A replay of the conference call will be available on the Gul

    2/10/26 4:10:00 PM ET
    $GPOR
    Oil & Gas Production
    Energy

    BRIXMOR PROPERTY GROUP REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

     - Delivered Record Annual Operating Results, Including Small Shop Occupancy -  - Executed a Record $70 Million of New Lease ABR -  NEW YORK, Feb. 9, 2026 /PRNewswire/ -- Brixmor Property Group Inc. (NYSE:BRX) ("Brixmor" or the "Company") announced today its operating results for the three and twelve months ended December 31, 2025.  For the three months ended December 31, 2025 and 2024, net income attributable to Brixmor Property Group Inc. was $0.44 per diluted share and $0.27 per diluted share, respectively, and for the twelve months ended December 31, 2025 and 2024, net income attributable to Brixmor Property Group Inc. was $1.25 per diluted share and $1.11 per diluted share, respective

    2/9/26 4:04:00 PM ET
    $BRX
    Real Estate Investment Trusts
    Real Estate

    $AMTX
    $AVAL
    $BRX
    $CBFV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Marqeta Inc.

    SC 13G/A - Marqeta, Inc. (0001522540) (Subject)

    11/27/24 8:47:26 PM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Gulfport Energy Corporation

    SC 13D/A - GULFPORT ENERGY CORP (0000874499) (Subject)

    11/25/24 7:34:56 PM ET
    $GPOR
    Oil & Gas Production
    Energy

    Amendment: SEC Form SC 13D/A filed by National CineMedia Inc.

    SC 13D/A - National CineMedia, Inc. (0001377630) (Subject)

    11/20/24 9:34:56 PM ET
    $NCMI
    Advertising
    Consumer Discretionary